International Journal of Clinical Oncology
Overview
The International Journal of Clinical Oncology is a reputable peer-reviewed journal that focuses on the latest advancements in the field of oncology. It publishes high-quality research articles, reviews, and case reports, covering various aspects of cancer diagnosis, treatment, and management. With a global perspective, this journal serves as a valuable resource for oncologists, researchers, and healthcare professionals involved in cancer care and aims to contribute to the improvement of patient outcomes worldwide.
Details
Details
Metrics
Metrics
h-index / Ranks: 4734
75
SJR / Ranks: 4146
950
CiteScore / Ranks: 3827
6.00
JIF / Ranks: 3040
3.3
Recent Articles
1.
Kokori E, Olatunji G, Ogieuhi I, Ajayi Y, Akinmoju O, Akinboade A, et al.
Int J Clin Oncol
. 2025 Mar;
PMID: 40080361
Colorectal cancer (CRC) poses a substantial global health challenge, ranking as the third most commonly diagnosed and second most fatal cancer worldwide. With an increasing incidence, particularly in older populations,...
2.
Baba T, Hiraike O, Iwase A, Tanimura S, Sunada M, Takenaka S, et al.
Int J Clin Oncol
. 2025 Mar;
PMID: 40057906
Minimally invasive surgery (MIS) for gynecologic cancers, which includes laparoscopic and robotic approaches, has seen significant growth in Japan over the past decade. While offering numerous benefits, including reduced postoperative...
3.
Tian Y, Zhang H, Xiang Z, Xu C, Xue H, Xu Q
Int J Clin Oncol
. 2025 Mar;
PMID: 40057905
Background: Periodic tryptophan protein 1 (PWP1) is a member of the WD-40 family, located at the nucleus. The study of PWP1 in malignant tumors is at the initial stage. Its...
4.
Ishida Y, Ikeda S, Harada T, Sakakibara-Konishi J, Yokoo K, Kikuchi H, et al.
Int J Clin Oncol
. 2025 Mar;
PMID: 40056277
Background: Interstitial pneumonia (IP) is a common comorbidity with poor prognosis in patients with non-small cell lung cancer (NSCLC) and a risk factor for immune checkpoint inhibitor (ICI)-induced pneumonitis. This...
5.
Tohi Y, Yokomizo A, Kimura T, Wakabayashi M, Shiota M, Mori K, et al.
Int J Clin Oncol
. 2025 Mar;
PMID: 40056276
Background: We have demonstrated that patients with prostate-specific antigen failure following radical prostatectomy benefit from salvage radiation therapy prior to salvage hormone therapy in a multicenter, randomized, open-label, phase 3...
6.
Oka K, Iwai N, Ohara T, Watanabe A, Okabe K, Ohara T, et al.
Int J Clin Oncol
. 2025 Mar;
PMID: 40056275
Background: Thromboembolism, including ischemic stroke and venous thromboembolism (VTE), is a critical complication in patients with advanced cancer. Pancreatic cancer and gastric cancer are classified as "very high risk" cancers...
7.
Iida Y, Kobayashi-Kato M, Komatsu H, Ishikawa M, Satoh T
Int J Clin Oncol
. 2025 Mar;
PMID: 40053172
Background: The significance of lymph node dissection (LND) in primary debulking surgery (PDS) for advanced ovarian cancer was demonstrated in the LION trial. However, the role and the current practices...
8.
Kobayashi H, Yanazume S, Kamio M, Togami S, Ushiwaka T
Int J Clin Oncol
. 2025 Mar;
PMID: 40038151
Objective: The importance of minimally invasive fertility-sparing surgery for cervical cancer is gaining increasing interest, both to achieve a cure and for future fertility. Procedures for robotic radical trachelectomy involving...
9.
Taguchi S, Kawai T, Kurokawa Y, Saegusa N, Yamamoto M, Ambe Y, et al.
Int J Clin Oncol
. 2025 Mar;
PMID: 40032741
Background: Dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (dd-MVAC) is an established regimen for advanced urothelial carcinoma (aUC). Although platinum-based chemotherapy, typically gemcitabine and cisplatin, followed by switch maintenance avelumab has...
10.
Ueda K, Ito N, Sakai Y, Ohnishi S, Hirano T, Kurose H, et al.
Int J Clin Oncol
. 2025 Mar;
PMID: 40024957
No abstract available.